These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16387998)

  • 1. Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
    Bhanji NH; Gauthier S
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):552-5. PubMed ID: 16387998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
    Bhasin M; Rowan E; Edwards K; McKeith I
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):890-5. PubMed ID: 17265415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil in the treatment of dementia with lewy bodies.
    Beversdorf DQ; Warner JL; Davis RA; Sharma UK; Nagaraja HN; Scharre DW
    Am J Geriatr Psychiatry; 2004; 12(5):542-4. PubMed ID: 15353396
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation.
    Anzellotti F; Bonanni L; Iorio E; Di Baldassarre F; D'Andreagiovanni A; Monaco D; Thomas A; Onofrj M
    Clin Neuropharmacol; 2008; 31(4):231-7. PubMed ID: 18670247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
    Ballard CG; Chalmers KA; Todd C; McKeith IG; O'Brien JT; Wilcock G; Love S; Perry EK
    Neurology; 2007 May; 68(20):1726-9. PubMed ID: 17502555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
    Kaufer DI
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies.
    Mori E; Ikeda M; Nakagawa M; Miyagishi H; Yamaguchi H; Kosaka K
    Dement Geriatr Cogn Disord; 2015; 40(3-4):186-98. PubMed ID: 26226884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
    Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of dementia with Lewy bodies.
    Josif S; Graham K
    JAAPA; 2008 May; 21(5):22-6. PubMed ID: 18556885
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring the role of donepezil in dementia with Lewy bodies.
    Szigeti K; Hafeez MU
    Drugs Today (Barc); 2015 Oct; 51(10):579-90. PubMed ID: 26583300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
    Mori S; Mori E; Iseki E; Kosaka K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.
    Manabe Y; Ino T; Yamanaka K; Kosaka K
    Psychogeriatrics; 2016 May; 16(3):202-8. PubMed ID: 26179411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis.
    Edwards KR; Hershey L; Wray L; Bednarczyk EM; Lichter D; Farlow M; Johnson S
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():40-8. PubMed ID: 14676468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of donepezil for the treatment of dementia with Lewy bodies.
    Rojas-Fernandez CH
    Ann Pharmacother; 2001 Feb; 35(2):202-5. PubMed ID: 11215841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of dementia with Lewy bodies that temporarily showed symptoms similar to Creutzfeldt-Jakob disease.
    Ukai K; Matsuo K; Nakamura R; Sobue G; Kosaka K; Shibayama H; Iritani S; Ishihara R; Ozaki N
    Psychogeriatrics; 2010 Dec; 10(4):201-5. PubMed ID: 21159056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor].
    Omerovic M; Teipel SJ; Hampel T
    Nervenarzt; 2007 Sep; 78(9):1052-7. PubMed ID: 17492420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
    Alwahhabi FK
    J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.